English  |  正體中文  |  简体中文  |  2826208  
???header.visitor??? :  31898202    ???header.onlineuser??? :  1485
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hsu c s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 66-90 of 309  (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T06:12:22Z Outcomes of HCV treatment: Who does well and who does not? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation Huang Z.-S.; Huang T.-S.; Wu T.-H.; Chen M.-F.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:20Z Hepatitis C infection and metabolic syndrome. Hsu C.S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:18Z Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:18Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:16Z Use of statins and gallstone risk [1] Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:11Z Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan Mah Y.-H.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:11Z Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:10Z HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection Hsu S.-J.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:08Z Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:07Z Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling Hsu C.-S.; Chen H.-C.; Jeng J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:07Z Boceprevir for chronic HCV genotype 1 infection [2] Hsu, C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:05Z Alpha-fetoprotein in chronic hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:04Z Hepatitis C virus and lipid profiles: More questions than answers? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:01Z Impact of hepatitis B virus infection on metabolic profiles and modifying factors Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:59Z Management of hepatitis C virus infection in the genomic era Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:58Z Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk Wang C.-C.; Tseng T.-C.; Hsieh T.-C.; Hsu C.-S.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:56Z Genomic variation-guided management in chronic hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:56Z Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:55Z Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals Liu C.-J.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Hsu C.-S.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:53Z IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:50Z Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO

Showing items 66-90 of 309  (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page